biotech · Non small cell lung cancer · oligometastatic hormone sensitive prostate cancer · CERO
CERo Therapeutics
CERO THERAPEUTICS HOLDINGS, INC.
News and analysis for CERo Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
201 Haskins Way, 230, South San Francisco, California 94080, US HQ
17 Employees
Public company Type
CERO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 201 Haskins Way, 230, South San Francisco, California 94080, US
- Employees
- 17
- Programs
- 47
- Drugs
- 84
- Patents
- 14
News & analysis
NovaPharmaNews articles mentioning CERo Therapeutics — regulatory, clinical, and market coverage.
News and analysis for CERo Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.